Rapross Pharmaceuticals Private Limited, a active private limited company, was established on 22 March 1995 in Delhi, Delhi, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U74899DL1995PTC066606. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹2.50 M.
It upholds a compliant status. Employing 326 professional, Its leadership includes Nimit Bansal (Additional Director), Sharad Verma (Additional Director), Parveen Kumar Bansal (Director). Past directors included Navneet Bagga, Parveen Kumar Bansal, Kanika Jain. It holds no open charges and ₹5.00 Cr settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at Ii Floor Garg Plaza, 5 Community Centre, Sector- 8 , Rohini, Delhi, Delhi, 110085.
U74899DL1995PTC066606
066606
22 March 1995
₹1.00 Cr
₹2.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Rapross Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nimit Bansal | Additional Director | 01 Sep 2023 | Current |
| Sharad Verma | Additional Director | 01 Sep 2023 | Current |
| Parveen Kumar Bansal | Director | 04 Apr 1995 | Current |
| Ranjan Verma | Director | 04 Apr 1995 | Current |
| Shailendra Singh | Additional Director | 11 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 01 Feb 2024 | Past |
| Pramod Abcsdd | Director | 06 Jul 2016 | Past |
| Pramod Abcsdd | Director | 25 Jul 2015 | Past |
| Pramod Abcsdd | Additional Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rapross Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.73% increase. The company also saw a slight decrease in profitability, with a 3.9% decrease in profit. The company's net worth Soared by an impressive increase of 11.86%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Rapross Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹50,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jul 2022 | Axis Bank Limited | ₹5.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Rapross Pharmaceuticals has a workforce of 326 employees as of Mar 20, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rapross Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rapross Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shailendra Singh was appointed as a Additional Director was appointed as a Additional Director on 11 Aug 2025 & has been associated with this company since 3 months 21 days . was recorded as a recent event.
The activity Rapross Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was completed.
The activity Rapross Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity Nimit Bansal was appointed as a Additional Director was appointed as a Additional Director on 01 Sep 2023 & has been associated with this company since 2 years 3 months . was completed.
The activity Sharad Verma was appointed as a Additional Director was appointed as a Additional Director on 01 Sep 2023 & has been associated with this company since 2 years 3 months . was completed.
A charge registered on 04 Jul 2022 via Charge ID 100597623 with Axis Bank Limited was fully satisfied on 28 Aug 2023. was recorded as a recent event.
The CIN of Rapross Pharmaceuticals Private Limited is U74899DL1995PTC066606.
Rapross Pharmaceuticals Private Limited is headquartered at Ii Floor Garg Plaza, 5 Community Centre, Sector- 8 , Rohini, Delhi, Delhi, 110085.
Rapross Pharmaceuticals Private Limited was incorporated on 22 March 1995.
The current directors of Rapross Pharmaceuticals Private Limited are
The primary industry of Rapross Pharmaceuticals Private Limited is Manufacturing.
Rapross Pharmaceuticals Private Limited is unlisted.
The authorized capital of Rapross Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹2.50 M.
The compliance status of Rapross Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX